This was the first randomized study to directly compare OROS MPH and atomoxetine in African-American children. Response in this population was consistent with that observed in the overall population. Both treatments demonstrated significant improvement from baseline; however, improvements noted in the OROS MPH group were consistently greater than those observed in the atomoxetine group. Differences [...]
A total of 1,323 patients were enrolled in this study; of these, 183 were African-American (OROS MPH: n=125, ato-moxetine: n=58). The mean age of the total African-American group was approximately nine years, and most (87%) patients were male (Table 1). The treatment groups were well matched with regard to baseline disease characteristics. Adherence to study [...]
Patients Eligible children were 6-12 years of age with a diagnosis of ADHD based on psychiatric history and a review of the DSM-IV diagnostic checklist. Children must have scored >24 on the ADHD-RS at screening and must have been rated “moderately ill” or worse on the CGI-SI. Newly diagnosed treatment-naive patients and previously diagnosed patients [...]
The most studied and most often used stimulant medication for attention-deficit/hyperactivity disorder (ADHD) is methylphenidate (MPH). By 1996, there were 133 randomized, controlled trials describing the treatment of ADHD with MPH. However, MPH has a short duration of effect that results in a need for multiple daily dosing. Therefore, several long-acting formulations have been developed [...]
Lastly, we will focus this year on strengthening our health disparity collaborations with two cultural giants in our community: the Black Church and the Black Press. Historically, the Black Church has been our bridge over troubled waters and a rest stop along the Underground Railroad. Today, we know that countless African-American churches across the country [...]
As I share with you our priorities for the coming year, I must emphasize that the overarching focus of our ongoing work at the NMA is to eradicate health disparities and create a healthier people.
Here again, if we “rewind the tape,” we see that this problem of unequal treatment in the U.S. healthcare system is not a new problem. The NMA was founded during early Jim Crow, when African Americans pursuing careers in medicine were banned from all-white medical schools and barred from hospital practices. It was a time [...]
